Meta-Analysis of Three Different Types of Fatigue Management Interventions for People with Multiple Sclerosis: Exercise, Education, and Medication
Fatigue is a common symptom of multiple sclerosis (MS) with negative impacts extending from general functioning to quality of life. Both the cause and consequences of MS fatigue are considered multidimensional and necessitate multidisciplinary treatment for successful symptom management. Clinical pr...
Uložené v:
| Vydané v: | Multiple Sclerosis International Ročník 2014; číslo 2014; s. 231 - 242 |
|---|---|
| Hlavní autori: | , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Cairo, Egypt
Hindawi Limiteds
01.01.2014
Hindawi Publishing Corporation Hindawi Limited John Wiley & Sons, Inc |
| Predmet: | |
| ISSN: | 2090-2654, 2090-2662 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Fatigue is a common symptom of multiple sclerosis (MS) with negative impacts extending from general functioning to quality of life. Both the cause and consequences of MS fatigue are considered multidimensional and necessitate multidisciplinary treatment for successful symptom management. Clinical practice guidelines suggest medication and rehabilitation for managing fatigue. This review summarized available research literature about three types of fatigue management interventions (exercise, education, and medication) to provide comprehensive perspective on treatment options and facilitate a comparison of their effectiveness. We researched PubMed, Embase, and CINAHL (August 2013). Search terms included multiple sclerosis, fatigue, energy conservation, Amantadine, Modafinil, and randomized controlled trial. The search identified 230 citations. After the full-text review, 18 rehabilitation and 7 pharmacological trials targeting fatigue were selected. Rehabilitation interventions appeared to have stronger and more significant effects on reducing the impact or severity of patient-reported fatigue compared to medication. Pharmacological agents, including fatigue medication, are important but often do not enable people with MS to cope with their existing disabilities. MS fatigue affects various components of one’s health and wellbeing. People with MS experiencing fatigue and their healthcare providers should consider a full spectrum of effective fatigue management interventions, from exercise to educational strategies in conjunction with medication. |
|---|---|
| AbstractList | Fatigue is a common symptom of multiple sclerosis (MS) with negative impacts extending from general functioning to quality of life. Both the cause and consequences of MS fatigue are considered multidimensional and necessitate multidisciplinary treatment for successful symptom management. Clinical practice guidelines suggest medication and rehabilitation for managing fatigue. This review summarized available research literature about three types of fatigue management interventions (exercise, education, and medication) to provide comprehensive perspective on treatment options and facilitate a comparison of their effectiveness. We researched PubMed, Embase, and CINAHL (August 2013). Search terms included multiple sclerosis, fatigue, energy conservation, Amantadine, Modafinil, and randomized controlled trial. The search identified 230 citations. After the full-text review, 18 rehabilitation and 7 pharmacological trials targeting fatigue were selected. Rehabilitation interventions appeared to have stronger and more significant effects on reducing the impact or severity of patient-reported fatigue compared to medication. Pharmacological agents, including fatigue medication, are important but often do not enable people with MS to cope with their existing disabilities. MS fatigue affects various components of one’s health and wellbeing. People with MS experiencing fatigue and their healthcare providers should consider a full spectrum of effective fatigue management interventions, from exercise to educational strategies in conjunction with medication. Fatigue is a common symptom of multiple sclerosis (MS) with negative impacts extending from general functioning to quality of life. Both the cause and consequences of MS fatigue are considered multidimensional and necessitate multidisciplinary treatment for successful symptom management. Clinical practice guidelines suggest medication and rehabilitation for managing fatigue. This review summarized available research literature about three types of fatigue management interventions (exercise, education, and medication) to provide comprehensive perspective on treatment options and facilitate a comparison of their effectiveness. We researched PubMed, Embase, and CINAHL (August 2013). Search terms included multiple sclerosis, fatigue, energy conservation, Amantadine, Modafinil, and randomized controlled trial. The search identified 230 citations. After the fulltext review, 18 rehabilitation and 7 pharmacological trials targeting fatigue were selected. Rehabilitation interventions appeared to have stronger and more significant effects on reducing the impact or severity of patient-reported fatigue compared to medication. Pharmacological agents, including fatigue medication, are important but often do not enable people with MS to cope with their existing disabilities. MS fatigue affects various components of one's health and wellbeing. People with MS experiencing fatigue and their healthcare providers should consider a full spectrum of effective fatigue management interventions, from exercise to educational strategies in conjunction with medication. Fatigue is a common symptom of multiple sclerosis (MS) with negative impacts extending from general functioning to quality of life. Both the cause and consequences of MS fatigue are considered multidimensional and necessitate multidisciplinary treatment for successful symptom management. Clinical practice guidelines suggest medication and rehabilitation for managing fatigue. This review summarized available research literature about three types of fatigue management interventions (exercise, education, and medication) to provide comprehensive perspective on treatment options and facilitate a comparison of their effectiveness. We researched PubMed, Embase, and CINAHL (August 2013). Search terms included multiple sclerosis, fatigue, energy conservation, Amantadine, Modafinil, and randomized controlled trial. The search identified 230 citations. After the full-text review, 18 rehabilitation and 7 pharmacological trials targeting fatigue were selected. Rehabilitation interventions appeared to have stronger and more significant effects on reducing the impact or severity of patient-reported fatigue compared to medication. Pharmacological agents, including fatigue medication, are important but often do not enable people with MS to cope with their existing disabilities. MS fatigue affects various components of one's health and wellbeing. People with MS experiencing fatigue and their healthcare providers should consider a full spectrum of effective fatigue management interventions, from exercise to educational strategies in conjunction with medication.Fatigue is a common symptom of multiple sclerosis (MS) with negative impacts extending from general functioning to quality of life. Both the cause and consequences of MS fatigue are considered multidimensional and necessitate multidisciplinary treatment for successful symptom management. Clinical practice guidelines suggest medication and rehabilitation for managing fatigue. This review summarized available research literature about three types of fatigue management interventions (exercise, education, and medication) to provide comprehensive perspective on treatment options and facilitate a comparison of their effectiveness. We researched PubMed, Embase, and CINAHL (August 2013). Search terms included multiple sclerosis, fatigue, energy conservation, Amantadine, Modafinil, and randomized controlled trial. The search identified 230 citations. After the full-text review, 18 rehabilitation and 7 pharmacological trials targeting fatigue were selected. Rehabilitation interventions appeared to have stronger and more significant effects on reducing the impact or severity of patient-reported fatigue compared to medication. Pharmacological agents, including fatigue medication, are important but often do not enable people with MS to cope with their existing disabilities. MS fatigue affects various components of one's health and wellbeing. People with MS experiencing fatigue and their healthcare providers should consider a full spectrum of effective fatigue management interventions, from exercise to educational strategies in conjunction with medication. |
| Audience | Academic |
| Author | Asano, Miho Finlayson, Marcia L. |
| AuthorAffiliation | School of Rehabilitation Therapy, Queen's University, Louise D. Acton Building, 31 George Street, Kingston, ON, Canada K7L 3N6 |
| AuthorAffiliation_xml | – name: School of Rehabilitation Therapy, Queen's University, Louise D. Acton Building, 31 George Street, Kingston, ON, Canada K7L 3N6 |
| Author_xml | – sequence: 1 fullname: Asano, Miho – sequence: 2 fullname: Finlayson, Marcia L. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24963407$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk1vEzEQhleoiJbSE3dkCQkhaFrb6_0wB6SqpFApEZUIZ2viHSeuNutg77bkb_CLcT5IkwqEfbDH88xre2aeJweNazBJXjJ6xliWnXPKxHkhS15mT5IjTiXt8TznB9t9Jg6TkxBuaRwZ5UWZPksOuZB5KmhxlPwaYgu9iwbqRbCBOENGU49IPllj0GPTktFijivHFbR20iEZQgMTnC19102L_i7urGsCMc6TG3TzGsm9badk2NWtXVrfdI3eRf0PpP8TvbYBT0m_6jQsA08JNBUZYmXX9ovkqYE64MlmPU6-X_VHl196g6-fry8vBj3IctH2DFQgcs0EgwKgKCXQfAzGgAAts1IWnBYSy4IhLQ0vpBTlGAuuUxznWgqRHicf17rzbjzDSsdveKjV3NsZ-IVyYNW-p7FTNXF3StCMUyGjwNuNgHc_Ogytmtmgsa6hQdcFxbKYYipEwSL6-hF66zofsx4Uj1CeFXkpH6gJ1KhsY1y8Vy9F1YXgTNL4Lxqps79QcVY4szq2h7HxfC_gzU7AFKFup8HV3apq--Cr3YxsU_GnXSLwfg3oWM7g0WwRRtWyH9WyH9W6HyPNHtHatqsSxwfb-h8x79YxU9tUcG__c8HmvRgRNLADizxneQQGawCst619SPpNlMkYZ5QytpJkXG2PKEsfGWmEBE9_A9ylC6I |
| CitedBy_id | crossref_primary_10_1080_09638288_2018_1496154 crossref_primary_10_1177_1352458520936231 crossref_primary_10_3389_fpsyg_2022_907637 crossref_primary_10_1186_s13167_016_0073_3 crossref_primary_10_1177_1545968318818904 crossref_primary_10_1007_s10620_020_06222_5 crossref_primary_10_1155_2015_123494 crossref_primary_10_1136_jnnp_2023_331537 crossref_primary_10_1186_s12883_019_1367_6 crossref_primary_10_3389_fneur_2018_00149 crossref_primary_10_1016_j_dhjo_2023_101549 crossref_primary_10_1016_j_msard_2023_104929 crossref_primary_10_1177_1352458517709361 crossref_primary_10_1080_10833196_2017_1315212 crossref_primary_10_1111_ane_13540 crossref_primary_10_1016_j_outlook_2017_03_013 crossref_primary_10_1007_s11910_016_0700_3 crossref_primary_10_1136_jnnp_2017_317463 crossref_primary_10_1177_15691861221137223 crossref_primary_10_3389_fneur_2014_00177 crossref_primary_10_1007_s11910_019_1002_3 crossref_primary_10_1080_11038128_2021_1905057 crossref_primary_10_3389_fpubh_2024_1387658 crossref_primary_10_1111_jocn_13788 crossref_primary_10_5014_ajot_2022_050088 crossref_primary_10_1016_j_msard_2022_104401 crossref_primary_10_1093_ecco_jcc_jjw029 crossref_primary_10_1177_13524585231215960 crossref_primary_10_1177_160940691501400206 crossref_primary_10_1177_1049732317753584 crossref_primary_10_1007_s10072_017_3047_x crossref_primary_10_1016_j_msard_2019_06_034 crossref_primary_10_1177_1479973119894855 crossref_primary_10_1136_jnnp_2018_320050 crossref_primary_10_1177_03080226231184708 crossref_primary_10_1177_15459683211046257 crossref_primary_10_2217_nmt_2020_0030 crossref_primary_10_1080_09638288_2023_2266363 crossref_primary_10_18863_pgy_1133369 crossref_primary_10_1080_09602011_2020_1808023 crossref_primary_10_3389_fimmu_2024_1379538 crossref_primary_10_1186_s12883_021_02084_0 crossref_primary_10_3389_fresc_2022_811465 crossref_primary_10_1007_s40120_019_00158_3 crossref_primary_10_1080_02701367_2015_1023099 crossref_primary_10_1177_1352458517732842 crossref_primary_10_1155_2019_2027947 crossref_primary_10_1177_13524585241292950 crossref_primary_10_1080_23311908_2024_2348060 crossref_primary_10_1177_2055217315585333 crossref_primary_10_1002_fsn3_70884 crossref_primary_10_1177_1352458521996002 crossref_primary_10_1371_journal_pone_0258752 crossref_primary_10_1111_ppc_12293 crossref_primary_10_1177_02692155251351510 crossref_primary_10_2147_NSS_S256676 crossref_primary_10_1007_s10826_017_1007_y crossref_primary_10_1136_bmjopen_2019_035470 crossref_primary_10_1016_j_msard_2018_03_020 crossref_primary_10_1155_2022_4590154 crossref_primary_10_1016_j_msard_2023_104720 crossref_primary_10_1007_s15202_018_1884_y crossref_primary_10_1177_13524585231204451 crossref_primary_10_1080_11038128_2022_2051600 crossref_primary_10_23949_kjpe_2025_7_64_4_31 crossref_primary_10_1080_09638288_2022_2069295 crossref_primary_10_3389_fneur_2022_891415 crossref_primary_10_1080_10833196_2017_1287393 crossref_primary_10_1177_1352458517702751 crossref_primary_10_1186_s12905_020_01109_z crossref_primary_10_1007_s00115_017_0442_8 crossref_primary_10_1177_1352458515606526 crossref_primary_10_2217_nmt_2017_0009 crossref_primary_10_1177_1352458519861267 crossref_primary_10_3389_fresc_2022_999266 crossref_primary_10_1007_s00115_016_0128_7 crossref_primary_10_1111_ene_16452 crossref_primary_10_3389_fpsyg_2021_598726 crossref_primary_10_1016_j_jocn_2025_111445 crossref_primary_10_1080_09638288_2023_2242783 crossref_primary_10_1177_1352458516681862 crossref_primary_10_1177_1352458517745723 crossref_primary_10_7224_1537_2073_2018_058 crossref_primary_10_1177_2055217321999826 crossref_primary_10_1080_14737175_2020_1796640 crossref_primary_10_1177_13524585231185462 crossref_primary_10_2196_19564 crossref_primary_10_12688_f1000research_18247_1 crossref_primary_10_1136_jnnp_2018_319496 crossref_primary_10_2147_NDT_S429862 crossref_primary_10_1186_s12883_019_1356_9 crossref_primary_10_3233_NRE_210179 |
| Cites_doi | 10.1097/PSY.0b013e31829b4525 10.1177/1352458511402410 10.1212/WNL.0b013e3181f4d80d 10.1017/S0317167100026603 10.1016/S0003-9993(03)00133-3 10.1177/1352458511404272 10.1093/clinids/18.Supplement_1.S79 10.1097/PSY.0b013e3181643065 10.1001/archneur.61.4.525 10.1097/PHM.0b013e3181d3e71f 10.1089/109350703321908441 10.1016/j.brat.2012.03.001 10.1179/1743132812Y.0000000081 10.2522/ptj.20100399 10.2337/diacare.24.3.561 10.1016/j.clineuro.2010.03.006 10.1016/j.apmr.2013.01.025 10.1191/1352458503ms904oa 10.1177/135245850000600308 10.1179/108331906X144154 10.1037/0033-2909.112.1.155 10.1177/1352458508101877 10.1191/1352458502ms779oa 10.1177/1352458507078392 10.1212/WNL.33.11.1444 10.1037/a0027890 10.1016/j.jval.2012.08.1926 10.1177/1352458509360040 10.1186/1477-7525-6-100 10.1212/01.WNL.0000129534.88602.5C 10.1016/S0738-3991(02)00032-0 10.1016/S0022-510X(02)00312-X 10.1093/jpepsy/jsp004 10.1212/01.WNL.0000158272.27070.6A 10.1001/archneur.1989.00520460115022 10.1111/j.1749-6632.1984.tb14805.x 10.1212/01.WNL.0000156803.23698.9A 10.1212/WNL.45.11.1956 10.1016/j.jns.2003.11.005 10.1188/11.CJON.438-439 10.1186/1748-5908-5-69 10.1136/bmj.d5928 10.1191/1352458505ms1198oa 10.1016/S1474-4422(05)70193-9 10.1177/1352458510364536 10.1136/jnnp.2005.064410 10.1177/135245850000600307 10.1097/01.PSY.0000074757.11682.96 10.1016/j.apmr.2012.05.006 10.1097/NPT.0b013e31820b5a9d 10.1191/135245801701567050 10.1111/j.1600-0404.2012.01660.x |
| ContentType | Journal Article |
| Copyright | Copyright © 2014 Miho Asano and Marcia L. Finlayson. COPYRIGHT 2014 Hindawi Limited Copyright © 2014 Miho Asano and Marcia L. Finlayson. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2014 M. Asano and M. L. Finlayson. 2014 |
| Copyright_xml | – notice: Copyright © 2014 Miho Asano and Marcia L. Finlayson. – notice: COPYRIGHT 2014 Hindawi Limited – notice: Copyright © 2014 Miho Asano and Marcia L. Finlayson. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2014 M. Asano and M. L. Finlayson. 2014 |
| DBID | 188 ADJCN AHFXO RHU RHW RHX AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1155/2014/798285 |
| DatabaseName | Chinese Electronic Periodical Services (CEPS) الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete Hindawi Publishing Complete Hindawi Publishing Subscription Journals Hindawi Publishing Open Access CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database CrossRef PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: RHX name: Hindawi Publishing Open Access url: http://www.hindawi.com/journals/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health Education |
| EISSN | 2090-2662 |
| Editor | Solari, Alessandra |
| Editor_xml | – sequence: 1 givenname: Alessandra surname: Solari fullname: Solari, Alessandra |
| EndPage | 242 |
| ExternalDocumentID | PMC4052049 A421909580 24963407 10_1155_2014_798285 1046616 P20151210011_201412_201512100013_201512100013_231_242 |
| Genre | Journal Article Review |
| GeographicLocations | Canada |
| GeographicLocations_xml | – name: Canada |
| GrantInformation_xml | – fundername: Consortium of Multiple Sclerosis Centers |
| GroupedDBID | --- 188 24P 2UF 4.4 53G 5VS 7X7 8FI 8FJ AAFWJ AAJEY ABDBF ABUWG ADBBV ADRAZ AFKRA AFPKN AINHJ ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV BENPR CCPQU CEFSP CNMHZ EBD EBS EJD ESX FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IEA IHR IHW ITC KQ8 M48 M~E OK1 PGMZT PIMPY RHX RNS RPM TUS UKHRP UZ5 0R~ AAMMB ACCMX ACUHS ADJCN AEFGJ AGXDD AHFXO AIDQK AIDYY IL9 PHGZM PHGZT PUEGO RHU RHW AAYXX AFFHD ALUQN CITATION NPM 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-a564t-fada46c141a7aa789a06baffa4ac958972079e871e08f279948be72c3eb6c9443 |
| IEDL.DBID | RHX |
| ISICitedReferencesCount | 180 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000215745600028&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2090-2654 |
| IngestDate | Tue Nov 04 02:02:25 EST 2025 Thu Sep 04 19:27:31 EDT 2025 Tue Oct 07 07:03:36 EDT 2025 Tue Nov 11 09:58:25 EST 2025 Tue Nov 04 17:57:20 EST 2025 Thu May 22 20:56:42 EDT 2025 Thu Apr 03 07:04:37 EDT 2025 Tue Nov 18 22:33:00 EST 2025 Sat Nov 29 02:54:09 EST 2025 Sun Jun 02 18:52:52 EDT 2024 Thu Sep 25 15:16:20 EDT 2025 Tue Oct 01 22:51:10 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2014 |
| Language | English |
| License | This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/3.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a564t-fada46c141a7aa789a06baffa4ac958972079e871e08f279948be72c3eb6c9443 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Academic Editor: Alessandra Solari |
| ORCID | 0000-0002-0043-8948 |
| OpenAccessLink | https://dx.doi.org/10.1155/2014/798285 |
| PMID | 24963407 |
| PQID | 2407657689 |
| PQPubID | 4727247 |
| PageCount | 12 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4052049 proquest_miscellaneous_1540704471 proquest_journals_2407657689 gale_infotracmisc_A421909580 gale_infotracacademiconefile_A421909580 gale_healthsolutions_A421909580 pubmed_primary_24963407 crossref_primary_10_1155_2014_798285 crossref_citationtrail_10_1155_2014_798285 hindawi_primary_10_1155_2014_798285 emarefa_primary_1046616 airiti_journals_P20151210011_201412_201512100013_201512100013_231_242 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-01-01 |
| PublicationDateYYYYMMDD | 2014-01-01 |
| PublicationDate_xml | – month: 01 year: 2014 text: 2014-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Cairo, Egypt |
| PublicationPlace_xml | – name: Cairo, Egypt – name: Egypt – name: New York |
| PublicationTitle | Multiple Sclerosis International |
| PublicationTitleAlternate | Mult Scler Int |
| PublicationYear | 2014 |
| Publisher | Hindawi Limiteds Hindawi Publishing Corporation Hindawi Limited John Wiley & Sons, Inc |
| Publisher_xml | – name: Hindawi Limiteds – name: Hindawi Publishing Corporation – name: Hindawi Limited – name: John Wiley & Sons, Inc |
| References | (8) 2011; 15 (24) 2005 (53) 2001; 7 Cochrane Collaboration Cochrane collaboration open learning material: diversity and heterogeneity 2002, http://www.cochrane-net.org/openlearning/index.htm (28) 2010; 16 National Multiple Sclerosis Society Treatment recommendations for managing fatigue 2013, http://www.nationalmssociety.org/about-multiple-sclerosis/what-we-know-about-ms/symptoms/fatigue/index.aspx (32) 2010; 89 (38) 2010; 75 Mayo Clinic Aspirin for treatment of multiple sclerosis-related fatigue ClinicalTrials.gov, NLM Identifier: NCT00467584, National Library of Medicine, Bethesda, Md, USA, 2007http://clinicaltrials.gov/show/NCT00467584 (51) 1984; 436 (33) 2011; 35 (15) 2012; 57 (35) 2011; 17 (29) 2002; 8 (31) 2003; 84 (25) 2012; 93 (26) 2011; 91 (7) 2003; 9 (30) 2006; 77 (10) 2013; 75 (27) 2010; 112 (14) 1989; 46 (48) 2011; 17 (12) 2012; 15 (1) 1994; 18 (17) 2003; 82 (56) 2003; 6 (42) 2003; 65 (47) 1987; 14 (5) 2006; 11 (41) 2008; 70 (60) 2012; 126 (36) 2005; 11 Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988 Hillsdale, NJ, USA Lawrence Erlbaum Associates (34) 2004; 62 (61) 2010; 5 (2) 2002; 205 (4) 2000; 6 (18) 2009; 34 (43) 2012; 34 (45) 2009; 43 (46) 1995; 45 (20) 1992; 112 (58) 2000; 6 (6) 2005; 4 Higgins J. P. Green S. Deeks J. Altman D. Cochrane Handbook for Systematic Reviews of Interventions: Analyzing Data and Undertaking Meta-Analysis 2008 Chichester, UK John Wiley & Sons (40) 2012; 50 (39) 2007; 13 (16) 2011; 343 (11) 2013; 94 (44) 2004; 218 (59) 2004; 61 (23) 2009; 15 (57) 2001; 24 (49) 2005; 64 (50) 1983; 33 (9) 2007 (52) 2005; 64 (37) 2010; 16 (55) 2002; 48 (3) 2008; 6 44 48 (21) 2008 53 11 55 12 15 59 16 18 2 3 5 6 7 8 60 61 20 23 25 26 27 28 29 (19) 1988 30 32 33 35 36 37 38 39 40 41 42 43 11289485 - Diabetes Care. 2001 Mar;24(3):561-87 20054744 - Neurol Neurochir Pol. 2009 Sep-Oct;43(5):428-32 22516321 - Behav Res Ther. 2012 Jun;50(6):415-21 20194584 - Mult Scler. 2010 Apr;16(4):480-90 20854677 - Implement Sci. 2010 Sep 20;5:69 22609300 - Arch Phys Med Rehabil. 2012 Oct;93(10):1701-8 11795455 - Mult Scler. 2001 Dec;7(6):354-8 20375125 - Mult Scler. 2010 Jun;16(6):724-32 19014588 - Health Qual Life Outcomes. 2008 Nov 14;6:100 19223279 - J Pediatr Psychol. 2009 Oct;34(9):917-28 19324979 - Mult Scler. 2009 Apr;15(4):412-21 23399455 - Arch Phys Med Rehabil. 2013 Jul;94(7):1360-76 11990874 - Mult Scler. 2002 Apr;8(2):161-8 23788693 - Psychosom Med. 2013 Jul-Aug;75(6):575-80 15824337 - Neurology. 2005 Apr 12;64(7):1139-43 21810580 - Clin J Oncol Nurs. 2011 Aug;15(4):438-9 22979982 - Neurol Res. 2012 Nov;34(9):854-8 14502033 - Am J Phys Med Rehabil. 2003 Oct;82(10 Suppl):S8-15 6598017 - Ann N Y Acad Sci. 1984;436:347-60 2803071 - Arch Neurol. 1989 Oct;46(10):1121-3 22404677 - Acta Neurol Scand. 2012 Dec;126(6):384-9 18256342 - Psychosom Med. 2008 Feb;70(2):205-13 12401421 - Patient Educ Couns. 2002 Oct -Nov;48(2):177-87 15096400 - Arch Neurol. 2004 Apr;61(4):525-8 15674920 - Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003980 22008217 - BMJ. 2011 Oct 18;343:d5928 12881823 - Arch Phys Med Rehabil. 2003 Jul;84(7):994-9 10871830 - Mult Scler. 2000 Jun;6(3):181-5 10871829 - Mult Scler. 2000 Jun;6(3):176-80 20216060 - Am J Phys Med Rehabil. 2010 Jun;89(6):446-57 14577900 - Dis Manag. 2003 Summer;6(2):63-71 21561960 - Mult Scler. 2011 Sep;17(9):1130-40 16168933 - Lancet Neurol. 2005 Oct;4(10):643-52 12409184 - J Neurol Sci. 2002 Dec 15;205(1):51-8 15824361 - Neurology. 2005 Apr 12;64(7):1267-9 12814166 - Mult Scler. 2003 Jun;9(3):219-27 8148458 - Clin Infect Dis. 1994 Jan;18 Suppl 1:S79-83 7501140 - Neurology. 1995 Nov;45(11):1956-61 21475078 - J Neurol Phys Ther. 2011 Mar;35(1):2-10 12883103 - Psychosom Med. 2003 Jul-Aug;65(4):542-7 2889518 - Can J Neurol Sci. 1987 Aug;14(3):273-8 17623738 - Mult Scler. 2007 Sep;13(8):996-1003 20876468 - Neurology. 2010 Sep 28;75(13):1141-9 17253480 - Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002818 19565683 - Psychol Bull. 1992 Jul;112(1):155-9 14759641 - J Neurol Sci. 2004 Mar 15;218(1-2):103-8 21561959 - Mult Scler. 2011 Aug;17(8):1002-9 21680771 - Phys Ther. 2011 Aug;91(8):1166-83 6685237 - Neurology. 1983 Nov;33(11):1444-52 22686554 - Rehabil Psychol. 2012 May;57(2):159-66 16193899 - Mult Scler. 2005 Oct;11(5):592-601 20371148 - Clin Neurol Neurosurg. 2010 Sep;112(7):597-601 15184614 - Neurology. 2004 Jun 8;62(11):2058-64 16543538 - J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):531-3 |
| References_xml | – volume: 112 start-page: 155 issue: 1 year: 1992 end-page: 159 ident: 20 article-title: A power primer – volume: 6 start-page: 63 issue: 2 year: 2003 end-page: 71 ident: 56 article-title: Interventions to improve chronic illness care: evaluating their effectiveness – reference: Higgins J. P. Green S. Deeks J. Altman D. Cochrane Handbook for Systematic Reviews of Interventions: Analyzing Data and Undertaking Meta-Analysis 2008 Chichester, UK John Wiley & Sons – volume: 17 start-page: 1130 issue: 9 year: 2011 end-page: 1140 ident: 35 article-title: Randomized trial of a teleconference-delivered fatigue management program for people with multiple sclerosis – volume: 34 start-page: 854 issue: 9 year: 2012 end-page: 858 ident: 43 article-title: Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study – volume: 62 start-page: 2058 issue: 11 year: 2004 end-page: 2064 ident: 34 article-title: Randomized controlled trial of yoga and exercise in multiple sclerosis – volume: 15 start-page: 438 issue: 4 year: 2011 end-page: 439 ident: 8 article-title: Pharmacologic treatments for fatigue associated with palliative care – volume: 64 start-page: 1139 issue: 7 year: 2005 end-page: 1143 ident: 49 article-title: Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study – reference: Cochrane Collaboration Cochrane collaboration open learning material: diversity and heterogeneity 2002, http://www.cochrane-net.org/openlearning/index.htm – volume: 16 start-page: 724 issue: 6 year: 2010 end-page: 732 ident: 37 article-title: Clinical trial of a formal group fatigue program in multiple sclerosis – volume: 9 start-page: 219 issue: 3 year: 2003 end-page: 227 ident: 7 article-title: Fatigue associated with multiple sclerosis: diagnosis, impact and management – volume: 65 start-page: 542 issue: 4 year: 2003 end-page: 547 ident: 42 article-title: Effects of treatment for depression on fatigue in multiple sclerosis – volume: 126 start-page: 384 issue: 6 year: 2012 end-page: 389 ident: 60 article-title: Fatigue and heat sensitivity in patients with multiple sclerosis – volume: 46 start-page: 1121 issue: 10 year: 1989 end-page: 1123 ident: 14 article-title: The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus – volume: 82 start-page: S8 issue: 10, supplement year: 2003 end-page: S15 ident: 17 article-title: Overview of clinical trials in medical rehabilitation: impetuses, challenges, and needed future directions – issue: 1 year: 2005 ident: 24 article-title: Exercise therapy for multiple sclerosis – volume: 17 start-page: 1002 issue: 8 year: 2011 end-page: 1009 ident: 48 article-title: HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis – volume: 57 start-page: 159 issue: 2 year: 2012 end-page: 166 ident: 15 article-title: Comparison of the psychometric properties of two fatigue scales in multiple sclerosis – volume: 64 start-page: 1267 issue: 7 year: 2005 end-page: 1269 ident: 52 article-title: A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis – volume: 436 start-page: 347 year: 1984 end-page: 360 ident: 51 article-title: Disability rating scales in multiple sclerosis – volume: 35 start-page: 2 issue: 1 year: 2011 end-page: 10 ident: 33 article-title: Effects of high-intensity resistance training on strength, mobility, balance, and fatigue in individuals with multiple sclerosis: a randomized controlled trial – reference: Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988 Hillsdale, NJ, USA Lawrence Erlbaum Associates – issue: 1 year: 2007 ident: 9 article-title: Amantadine for fatigue in multiple sclerosis – volume: 16 start-page: 480 issue: 4 year: 2010 end-page: 490 ident: 28 article-title: Fatigue, mood and quality of life improve in MS patients after progressive resistance training – volume: 91 start-page: 1166 issue: 8 year: 2011 end-page: 1183 ident: 26 article-title: Effects of vestibular rehabilitation on multiple sclerosis-related fatigue and upright postural control: a randomized controlled trial – volume: 5 year: 2010 ident: 61 article-title: Scoping studies: advancing the methodology – volume: 33 start-page: 1444 issue: 11 year: 1983 end-page: 1452 ident: 50 article-title: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) – volume: 34 start-page: 917 issue: 9 year: 2009 end-page: 928 ident: 18 article-title: How to select, calculate, and interpret effect sizes – volume: 24 start-page: 561 issue: 3 year: 2001 end-page: 587 ident: 57 article-title: Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials – reference: National Multiple Sclerosis Society Treatment recommendations for managing fatigue 2013, http://www.nationalmssociety.org/about-multiple-sclerosis/what-we-know-about-ms/symptoms/fatigue/index.aspx – volume: 18 start-page: S79 year: 1994 end-page: S83 ident: 1 article-title: Measuring the functional impact of fatigue: initial validation of the fatigue impact scale – volume: 15 start-page: 412 issue: 4 year: 2009 end-page: 421 ident: 23 article-title: What does a structured review of the effectiveness of exercise interventions for persons with multiple sclerosis tell us about the challenges of designing trials? – volume: 6 start-page: 176 issue: 3 year: 2000 end-page: 180 ident: 58 article-title: Effect of precooling on physical performance in multiple sclerosis – volume: 89 start-page: 446 issue: 6 year: 2010 end-page: 457 ident: 32 article-title: Cycling progressive resistance training for people with multiple sclerosis: a randomized controlled study – volume: 13 start-page: 996 issue: 8 year: 2007 end-page: 1003 ident: 39 article-title: Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial – volume: 218 start-page: 103 issue: 1-2 year: 2004 end-page: 108 ident: 44 article-title: Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial – volume: 75 start-page: 575 issue: 6 year: 2013 end-page: 580 ident: 10 article-title: Effects of exercise training on fatigue in multiple sclerosis: a meta-analysis – volume: 45 start-page: 1956 issue: 11 year: 1995 end-page: 1961 ident: 46 article-title: Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo – volume: 205 start-page: 51 issue: 1 year: 2002 end-page: 58 ident: 2 article-title: Quality of life in patients with multiple sclerosis: the impact of fatigue and depression – volume: 93 start-page: 1701 issue: 10 year: 2012 end-page: 1708 ident: 25 article-title: Effect of aquatic exercise training on fatigue and health-related quality of life in patients with multiple sclerosis – volume: 343 year: 2011 ident: 16 article-title: The Cochrane collaboration's tool for assessing risk of bias in randomised trials – volume: 11 start-page: 235 issue: 4 year: 2006 end-page: 245 ident: 5 article-title: Understanding fatigue in multiple sclerosis – volume: 4 start-page: 643 issue: 10 year: 2005 end-page: 652 ident: 6 article-title: Symptomatic therapy and neurorehabilitation in multiple sclerosis – volume: 6 start-page: 181 issue: 3 year: 2000 end-page: 185 ident: 4 article-title: Fatigue in multiple sclerosis and its relationship to depression and neurologic disability – volume: 7 start-page: 354 issue: 6 year: 2001 end-page: 358 ident: 53 article-title: Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine – volume: 11 start-page: 592 issue: 5 year: 2005 end-page: 601 ident: 36 article-title: Randomized controlled trial of an energy conservation course for persons with multiple sclerosis – volume: 6 year: 2008 ident: 3 article-title: Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey – volume: 94 start-page: 1360 issue: 7 year: 2013 end-page: 1376 ident: 11 article-title: Effectiveness of energy conservation treatment in reducing fatigue in multiple sclerosis: a systematic review and meta-analysis – volume: 75 start-page: 1141 issue: 13 year: 2010 end-page: 1149 ident: 38 article-title: MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial – volume: 14 start-page: 273 issue: 3 year: 1987 end-page: 278 ident: 47 article-title: A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group – volume: 48 start-page: 177 issue: 2 year: 2002 end-page: 187 ident: 55 article-title: Self-management approaches for people with chronic conditions: a review – reference: Mayo Clinic Aspirin for treatment of multiple sclerosis-related fatigue ClinicalTrials.gov, NLM Identifier: NCT00467584, National Library of Medicine, Bethesda, Md, USA, 2007http://clinicaltrials.gov/show/NCT00467584 – volume: 61 start-page: 525 issue: 4 year: 2004 end-page: 528 ident: 59 article-title: The relationship of sleep disturbances and fatigue in multiple sclerosis – volume: 77 start-page: 531 issue: 4 year: 2006 end-page: 533 ident: 30 article-title: Treadmill training for individuals with multiple sclerosis: a pilot randomised trial – volume: 50 start-page: 415 issue: 6 year: 2012 end-page: 421 ident: 40 article-title: A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue – volume: 70 start-page: 205 issue: 2 year: 2008 end-page: 213 ident: 41 article-title: A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue – volume: 43 start-page: 428 issue: 5 year: 2009 end-page: 432 ident: 45 article-title: Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis? – volume: 8 start-page: 161 issue: 2 year: 2002 end-page: 168 ident: 29 article-title: Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis – volume: 15 start-page: A545 issue: 7 year: 2012 end-page: A546 ident: 12 article-title: Effect of cognitive behavioural therapy on multiple sclerosis fatigue: a systematic review of randomised control trials – volume: 112 start-page: 597 issue: 7 year: 2010 end-page: 601 ident: 27 article-title: Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis – volume: 84 start-page: 994 issue: 7 year: 2003 end-page: 999 ident: 31 article-title: Effect of inspiratory muscle training in patients with multiple sclerosis – volume: 75 start-page: 575 issue: 6 year: 2013 ident: 10 publication-title: Psychosomatic Medicine doi: 10.1097/PSY.0b013e31829b4525 – ident: 48 doi: 10.1177/1352458511402410 – ident: 38 doi: 10.1212/WNL.0b013e3181f4d80d – volume: 14 start-page: 273 issue: 3 year: 1987 ident: 47 publication-title: The Canadian Journal of Neurological Sciences doi: 10.1017/S0317167100026603 – volume: 84 start-page: 994 issue: 7 year: 2003 ident: 31 publication-title: Archives of Physical Medicine and Rehabilitation doi: 10.1016/S0003-9993(03)00133-3 – ident: 35 doi: 10.1177/1352458511404272 – volume: 18 start-page: S79 year: 1994 ident: 1 publication-title: Clinical Infectious Diseases doi: 10.1093/clinids/18.Supplement_1.S79 – ident: 41 doi: 10.1097/PSY.0b013e3181643065 – ident: 59 doi: 10.1001/archneur.61.4.525 – ident: 32 doi: 10.1097/PHM.0b013e3181d3e71f – volume: 6 start-page: 63 issue: 2 year: 2003 ident: 56 publication-title: Disease Management doi: 10.1089/109350703321908441 – ident: 40 doi: 10.1016/j.brat.2012.03.001 – ident: 43 doi: 10.1179/1743132812Y.0000000081 – ident: 26 doi: 10.2522/ptj.20100399 – volume: 24 start-page: 561 issue: 3 year: 2001 ident: 57 publication-title: Diabetes Care doi: 10.2337/diacare.24.3.561 – issue: 1 year: 2005 ident: 24 publication-title: The Cochrane Database of Systematic Reviews – ident: 27 doi: 10.1016/j.clineuro.2010.03.006 – ident: 11 doi: 10.1016/j.apmr.2013.01.025 – issue: 1 year: 2007 ident: 9 publication-title: The Cochrane Database of Systematic Reviews – ident: 7 doi: 10.1191/1352458503ms904oa – volume: 6 start-page: 181 issue: 3 year: 2000 ident: 4 publication-title: Multiple Sclerosis doi: 10.1177/135245850000600308 – ident: 5 doi: 10.1179/108331906X144154 – ident: 20 doi: 10.1037/0033-2909.112.1.155 – ident: 23 doi: 10.1177/1352458508101877 – ident: 29 doi: 10.1191/1352458502ms779oa – ident: 39 doi: 10.1177/1352458507078392 – volume: 33 start-page: 1444 issue: 11 year: 1983 ident: 50 publication-title: Neurology doi: 10.1212/WNL.33.11.1444 – ident: 15 doi: 10.1037/a0027890 – year: 2008 ident: 21 – ident: 12 doi: 10.1016/j.jval.2012.08.1926 – ident: 28 doi: 10.1177/1352458509360040 – ident: 3 doi: 10.1186/1477-7525-6-100 – volume: 62 start-page: 2058 issue: 11 year: 2004 ident: 34 publication-title: Neurology doi: 10.1212/01.WNL.0000129534.88602.5C – ident: 55 doi: 10.1016/S0738-3991(02)00032-0 – ident: 2 doi: 10.1016/S0022-510X(02)00312-X – ident: 18 doi: 10.1093/jpepsy/jsp004 – volume: 64 start-page: 1139 issue: 7 year: 2005 ident: 49 publication-title: Neurology doi: 10.1212/01.WNL.0000158272.27070.6A – volume: 46 start-page: 1121 issue: 10 year: 1989 ident: 14 publication-title: Archives of Neurology doi: 10.1001/archneur.1989.00520460115022 – volume: 82 start-page: S8 issue: 10, supplement year: 2003 ident: 17 publication-title: American Journal of Physical Medicine & Rehabilitation – volume: 436 start-page: 347 year: 1984 ident: 51 publication-title: Annals of the New York Academy of Sciences doi: 10.1111/j.1749-6632.1984.tb14805.x – volume: 64 start-page: 1267 issue: 7 year: 2005 ident: 52 publication-title: Neurology doi: 10.1212/01.WNL.0000156803.23698.9A – volume: 45 start-page: 1956 issue: 11 year: 1995 ident: 46 publication-title: Neurology doi: 10.1212/WNL.45.11.1956 – year: 1988 ident: 19 – ident: 44 doi: 10.1016/j.jns.2003.11.005 – ident: 8 doi: 10.1188/11.CJON.438-439 – ident: 61 doi: 10.1186/1748-5908-5-69 – ident: 16 doi: 10.1136/bmj.d5928 – ident: 36 doi: 10.1191/1352458505ms1198oa – ident: 6 doi: 10.1016/S1474-4422(05)70193-9 – ident: 37 doi: 10.1177/1352458510364536 – ident: 30 doi: 10.1136/jnnp.2005.064410 – volume: 6 start-page: 176 issue: 3 year: 2000 ident: 58 publication-title: Multiple Sclerosis doi: 10.1177/135245850000600307 – ident: 42 doi: 10.1097/01.PSY.0000074757.11682.96 – volume: 43 start-page: 428 issue: 5 year: 2009 ident: 45 publication-title: Neurologia i Neurochirurgia Polska – ident: 25 doi: 10.1016/j.apmr.2012.05.006 – ident: 33 doi: 10.1097/NPT.0b013e31820b5a9d – ident: 53 doi: 10.1191/135245801701567050 – ident: 60 doi: 10.1111/j.1600-0404.2012.01660.x – reference: 23788693 - Psychosom Med. 2013 Jul-Aug;75(6):575-80 – reference: 10871830 - Mult Scler. 2000 Jun;6(3):181-5 – reference: 15096400 - Arch Neurol. 2004 Apr;61(4):525-8 – reference: 21810580 - Clin J Oncol Nurs. 2011 Aug;15(4):438-9 – reference: 22008217 - BMJ. 2011 Oct 18;343:d5928 – reference: 18256342 - Psychosom Med. 2008 Feb;70(2):205-13 – reference: 20876468 - Neurology. 2010 Sep 28;75(13):1141-9 – reference: 22686554 - Rehabil Psychol. 2012 May;57(2):159-66 – reference: 20194584 - Mult Scler. 2010 Apr;16(4):480-90 – reference: 11795455 - Mult Scler. 2001 Dec;7(6):354-8 – reference: 22979982 - Neurol Res. 2012 Nov;34(9):854-8 – reference: 14759641 - J Neurol Sci. 2004 Mar 15;218(1-2):103-8 – reference: 6598017 - Ann N Y Acad Sci. 1984;436:347-60 – reference: 21561959 - Mult Scler. 2011 Aug;17(8):1002-9 – reference: 21561960 - Mult Scler. 2011 Sep;17(9):1130-40 – reference: 21475078 - J Neurol Phys Ther. 2011 Mar;35(1):2-10 – reference: 15184614 - Neurology. 2004 Jun 8;62(11):2058-64 – reference: 20371148 - Clin Neurol Neurosurg. 2010 Sep;112(7):597-601 – reference: 12401421 - Patient Educ Couns. 2002 Oct -Nov;48(2):177-87 – reference: 12814166 - Mult Scler. 2003 Jun;9(3):219-27 – reference: 22404677 - Acta Neurol Scand. 2012 Dec;126(6):384-9 – reference: 16543538 - J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):531-3 – reference: 20054744 - Neurol Neurochir Pol. 2009 Sep-Oct;43(5):428-32 – reference: 19223279 - J Pediatr Psychol. 2009 Oct;34(9):917-28 – reference: 15674920 - Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003980 – reference: 16168933 - Lancet Neurol. 2005 Oct;4(10):643-52 – reference: 2803071 - Arch Neurol. 1989 Oct;46(10):1121-3 – reference: 23399455 - Arch Phys Med Rehabil. 2013 Jul;94(7):1360-76 – reference: 14502033 - Am J Phys Med Rehabil. 2003 Oct;82(10 Suppl):S8-15 – reference: 7501140 - Neurology. 1995 Nov;45(11):1956-61 – reference: 19014588 - Health Qual Life Outcomes. 2008 Nov 14;6:100 – reference: 12883103 - Psychosom Med. 2003 Jul-Aug;65(4):542-7 – reference: 17253480 - Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002818 – reference: 6685237 - Neurology. 1983 Nov;33(11):1444-52 – reference: 22609300 - Arch Phys Med Rehabil. 2012 Oct;93(10):1701-8 – reference: 20854677 - Implement Sci. 2010 Sep 20;5:69 – reference: 12409184 - J Neurol Sci. 2002 Dec 15;205(1):51-8 – reference: 16193899 - Mult Scler. 2005 Oct;11(5):592-601 – reference: 14577900 - Dis Manag. 2003 Summer;6(2):63-71 – reference: 12881823 - Arch Phys Med Rehabil. 2003 Jul;84(7):994-9 – reference: 22516321 - Behav Res Ther. 2012 Jun;50(6):415-21 – reference: 11990874 - Mult Scler. 2002 Apr;8(2):161-8 – reference: 8148458 - Clin Infect Dis. 1994 Jan;18 Suppl 1:S79-83 – reference: 20375125 - Mult Scler. 2010 Jun;16(6):724-32 – reference: 21680771 - Phys Ther. 2011 Aug;91(8):1166-83 – reference: 15824337 - Neurology. 2005 Apr 12;64(7):1139-43 – reference: 15824361 - Neurology. 2005 Apr 12;64(7):1267-9 – reference: 11289485 - Diabetes Care. 2001 Mar;24(3):561-87 – reference: 2889518 - Can J Neurol Sci. 1987 Aug;14(3):273-8 – reference: 20216060 - Am J Phys Med Rehabil. 2010 Jun;89(6):446-57 – reference: 19565683 - Psychol Bull. 1992 Jul;112(1):155-9 – reference: 10871829 - Mult Scler. 2000 Jun;6(3):176-80 – reference: 19324979 - Mult Scler. 2009 Apr;15(4):412-21 – reference: 17623738 - Mult Scler. 2007 Sep;13(8):996-1003 |
| SSID | ssj0000502783 |
| Score | 2.3467073 |
| SecondaryResourceType | review_article |
| Snippet | Fatigue is a common symptom of multiple sclerosis (MS) with negative impacts extending from general functioning to quality of life. Both the cause and... |
| SourceID | pubmedcentral proquest gale pubmed crossref hindawi emarefa airiti |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 231 |
| SubjectTerms | Amantadine Analysis Behavior modification Bias Care and treatment Complications and side effects Confidence intervals Dosage and administration Education Exercise Fatigue Health aspects Intervention Meta-analysis Multiple sclerosis Patient outcomes Psychotherapy Quality of life Rehabilitation Review Risk factors Standard deviation Therapy |
| SummonAdditionalLinks | – databaseName: ProQuest Publicly Available Content Database dbid: PIMPY link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELagYxIS4seAEShgxCQktKhJeoljXtAErZhEp0oMNJ4ix3FYpZGOpYX_g7-Yu9hNm2naE29NfXJt98vd-Xz-jrE9RW4yYsUXcWF80EL56CWE_hBkGUdFIIuGnf_bZ3F0lJ6cyKm7Hl27tMqVTmwUtWV7prxtVMKDYq4pYj6gfUhCrrJ8f_7LpxpSdNbqCmrcZFtEvJX22Nb0cDL93sZcgpjO2ejQOQpk4EdJDO7KHlrVAZpCGAhJlG5ojtSMSIU61mrb_FT4QbXae_uU9s1_Zld5p5eTLDes1vje_53vfXbXea_8wMLtAbthqh0q_OySRHbYHRsG5PZ200P2d2IWyl8xn_B5yY8RPIZ_dHVZFpw2wk3DGLv4sTR8nZDDDzcSMmuO7jWfNgnvnKLHfOJyIfkXHAsu36x-x0eugtQ-bwe1z1VVcHsgRc-P2Nfx6PjDJ9-VgfBVnMDCL1WhINEhhEooJVKpgiRXZalAaRmnUkSBkAY3fiZIy0hICWluRKSHJk-0BBg-Zr1qXpknjCsKm8UhrmMBoFWeKijCUKQ6KcIoySOPjez_nrk3uc6mCIuYWNZQEWYEkTDK2q_Qf770MEQhwH7ermCTace1TiU_zrJmzxXHTU-ZBZvH9lrhc0sxcrXYrsPfhhSge5V47CXhMbM3Z1uVlR0AmiN0odPAY28aCVJaOA6t3N0LXBWi_-pI9juSqGx0p_m1w_z1Q-2vML1eyDWEPfaqbab-Kc2vMvNlnYVEBxkAOkw4W_v6tL8TAdoKbPaY6LxYrQARpXdbqtlpQ5gOlOwF8un1w3rGbtMcbHytz3qLi6V5zm7p34tZffHC6ZJ_5iZ6Pg priority: 102 providerName: ProQuest |
| Title | Meta-Analysis of Three Different Types of Fatigue Management Interventions for People with Multiple Sclerosis: Exercise, Education, and Medication |
| URI | https://www.airitilibrary.com/Article/Detail/P20151210011-201412-201512100013-201512100013-231-242 https://search.emarefa.net/detail/BIM-1046616 https://dx.doi.org/10.1155/2014/798285 https://www.ncbi.nlm.nih.gov/pubmed/24963407 https://www.proquest.com/docview/2407657689 https://www.proquest.com/docview/1540704471 https://pubmed.ncbi.nlm.nih.gov/PMC4052049 |
| Volume | 2014 |
| WOSCitedRecordID | wos000215745600028&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2090-2662 dateEnd: 20240131 omitProxy: false ssIdentifier: ssj0000502783 issn: 2090-2654 databaseCode: 7X7 dateStart: 20130101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2090-2662 dateEnd: 20240131 omitProxy: false ssIdentifier: ssj0000502783 issn: 2090-2654 databaseCode: BENPR dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2090-2662 dateEnd: 20240131 omitProxy: false ssIdentifier: ssj0000502783 issn: 2090-2654 databaseCode: PIMPY dateStart: 20130101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 2090-2662 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000502783 issn: 2090-2654 databaseCode: 24P dateStart: 20100101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1fb9MwELfYYBISQvwnUIoRk5DQIpLUjmPeBrTaJFpFY6DuKbo6DqsEKVpa-B58Yu4SN2vKhHhJ497FcXKX8519_pmxfSA3GXXFVzK3vjAKfPQSQn8gdCGjPNB5jc7_5aOaTJLpVKcuQbb6ewofezsMz0PxRmmCWtthO4kk3T05mrYjKYGk2TOaSo4CHfhRLIVbiLd1NXYyMCeooE4ftGe_A55Aa5P3zika_jW_yufcTp3c6ItGd9ht50Tyw0bqd9k1W95jt5oRON4sLLrPfo_tEvw16AhfFPwU5Wb5B7clypJTDFoTRiieryvLL3Nh-PFGLmTF0bPlaZ1rzmnglo9dGiL_hPfHZ5xXb_nQbd50wNukkQMOZc6buSAqP2CfR8PT90e-24HBBxmLpV9ADiI2oQhBAahEQxDPoChAgNEy0SoKlLYYc9kgKSKltUhmVkVmYGex0UIMHrLdclHax4wDjVjJEKObXAgDswREHoYqMXEeRvEs8tiwEU7mPqIqS1F2kgDO0AZlJMcwytq_0HXdKgyQSWA9r9eyzYyDOafdNr5ldbgjZV1T1miEx_Zb5h8NusfVbI-ckmxwCfRsYo89J6XJmkWrrbXIDgX2BOi9JoHHXtUcZC-wHQbcsgd8K4S81eHsdTjxOzcd8kunmP9uam-ttJcvkqL2mAJL7bEXLZnqpwy70i5WVRYSEmMg0FfBp210vL0PhujxAMkeUx3tbxkIo7xLKefnNVa5oDwroZ_8V-OfsptUaka4emx3ebGyz9gN83M5ry76bEdNVX1M-uz6u-EkPcHf9HicnvVri_AHClNNZQ |
| linkProvider | Hindawi Publishing |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1R1db9Mw0BqDCSTEx_gKFGbEEBJa1MR14hgJoYm1WrW2qkRBfQuu47BKkI6lZeJv8EP4jdwlbtpM0972wFtTn5yLfd8-3xGyq9BMBlpxRZAYl2uhXLASfLfFZRqwxJNJUZ3_S08MBtF4LIcb5O_yLgymVS5lYiGok5nGGHkTPY8QjWP54eSni12j8HR12UKjJIsj8_sMXLb8ffcA9vc1Y5326OOha7sKuCoI-dxNVaJ4qH3uK6GUiKTywolKU8WVlkEkBfOENOBHGC9KmZCSRxMjmG6ZSagl5y2Y9xq5DnJcYAqZGIsqpuMFeI6Hh9rMk57LwoDbK4GgtZuganlTSCwZB-pOTbFoUU0bbpkfCn6oSjtsHaNffja9yPo9n8S5phU7d_-39bxH7lj7m-6XDHOfbJhsG1tX2zSXbXK7DGTS8n7WA_Knb-bKXdZuobOUjoD8DT2wnWXmFF35YqADU3xbGLpKKaLdtZTSnIKDQIdFyj7F-Dft22xO-glwgQ2a5u9o2_bA2qMVUntUZQktj9Tw-SH5fCVL9IhsZrPMPCFUYeAv8GHfEs61mkSKJ74vIh0mPgsnzCHtkrJiK4vyeAiEF2CdOBDlMRKhz-LqL_AAzj20AIjDPG-XhBlrWy0em5Z8jwuvMQiKmeKSnB2yWwGflEVSLgZ7bCl8DYqDgRg6ZAcpPi7v_lZCN97noFDBCYg8h7wpIFDsAh5a2dsjsCpYwKwG2ahBgrjUteFXlqsuR7Wx5JrVQq5YxiEvq2GcHxMVMzNb5LGPBS09DiYffG3JoNV7GAdtB8MOETXWrQCw1Ht9JJseFyXfOaarcfn0crR2yM3DUb8X97qDo2fkFn5PGS1skM356cI8Jzf0r_k0P31RyC1Kvl41Y_8D4FHKuA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1R1db9Mw0BqDISTEx_gKFGbEEBJa1MRx4hgJoYm2otpWVWJDfQuu47BKkI61ZeJv8HP4ddwlTtpM0972wFtTn5yLfd8-3xGyrdBMBlpxRZgal2uhXLASfDfgMgtZ6sm0qM7_ZV8MBvFoJIdr5G91FwbTKiuZWAjqdKoxRt5GzyNC41i2M5sWMez0Ppz8dLGDFJ60Vu00ShLZM7_PwH2bve93YK9fM9brHn785NoOA64KIz53M5UqHmmf-0ooJWKpvGisskxxpWUYS8E8IQ34FMaLMyak5PHYCKYDM4605DyAea-R6yIIBLaNECNRx3e8EM_08ICbedJzWRRyez0QNHgb1C5vC4nl40D1qQkWMGpoxg3zQ8EPVWuKjWP00c8mF1nC5xM6VzRk7-7_vLb3yB1rl9PdkpHukzWTb2JLa5v-sklulwFOWt7bekD-HJi5cquaLnSa0UNgC0M7tuPMnKKLXwz0YIpvC0OXqUa0v5JqOqPgONBhkcpPMS5OD2yWJ_0MuMBmTWbvaNf2xtqhNVI7VOUpLY_a8PkhObqSJXpE1vNpbp4QqjAgGPqwhynnWo1jxVPfF7GOUp9FY-aQbklliZVRs2QIRBhi_TgQ8QkSpM-S-i_wDM49BADEYZ63FZEm2laRx2Ym35PCmwzDYqakJG2HbNfAJ2XxlIvBHltqX4HiYDhGDtlC6k_KO8G1ME52OShacA5izyFvCggUx4CHVvZWCawKFjZrQLYakCBGdWP4leWwy1FtVRy0XMgl-zjkZT2M82MCY26mi1niY6FLj4MpCF9bMmv9HsZBC8KwQ0SDjWsALAHfHMknx0UpeI5pbFw-vRytLXIT-DnZ7w_2npFb-DllELFF1uenC_Oc3NC_5pPZ6YtChFHy9ar5-h_EsNNs |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Meta-analysis+of+three+different+types+of+fatigue+management+interventions+for+people+with+multiple+sclerosis%3A+exercise%2C+education%2C+and+medication&rft.jtitle=Multiple+sclerosis+international&rft.au=Asano%2C+Miho&rft.au=Finlayson%2C+Marcia+L&rft.date=2014-01-01&rft.pub=Hindawi+Limited&rft.issn=2090-2654&rft_id=info:doi/10.1155%2F2014%2F798285&rft.externalDocID=A421909580 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fwww.airitilibrary.com%2Fjnltitledo%2FP20151210011-c.jpg |